Veracyte (VCYT) Capital Expenditures Growth (5y) (2017 - 2026)
Veracyte (VCYT) Capital Expenditures Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Veracyte | 3.62 Bn | 3.32 Bn | 108.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.36% |
| Mar 31, 2026 | 19.89% |
| Dec 31, 2025 | 33.60% |
| Sep 30, 2025 | 34.47% |
| Jun 30, 2025 | 14.66% |
| Mar 31, 2025 | 22.29% |
| Dec 31, 2024 | 30.36% |
| Sep 30, 2024 | 57.41% |
| Jun 30, 2024 | 33.27% |
| Mar 31, 2024 | 22.77% |
| Dec 31, 2023 | 40.63% |
| Sep 30, 2023 | 33.57% |
| Jun 30, 2023 | 41.58% |
| Mar 31, 2023 | 48.22% |
| Dec 31, 2022 | 44.22% |
| Sep 30, 2022 | 18.71% |
| Jun 30, 2022 | 85.92% |
| Mar 31, 2022 | 31.88% |
| Dec 31, 2021 | 13.32% |
| Sep 30, 2021 | 59.96% |